Management of Post-Myocardial Infarction (MI) Patients
Introduction to Management
- The American Heart Association recommends considering reducing aspirin dose to 75-81 mg while maintaining P2Y12 inhibitor for patients with moderate bleeding 1
- Estrogen therapy increases thrombotic risk and should be used with extreme caution in post-MI patients, especially within the first month, according to the European Society of Cardiology 2
Cardiac Monitoring and Support
- Consider intra-aortic balloon pump support if patient becomes hemodynamically unstable, as suggested by the American College of Cardiology 3
- Monitor for at least 24 hours after reperfusion, as recommended by the American College of Cardiology and European Society of Cardiology 4, 5
- Consider non-invasive imaging to assess left ventricular function, according to the European Society of Cardiology 4
Management of Bleeding Based on Time Post-MI
- For patients <2 weeks post-MI, extreme caution with any interventional procedures is recommended by the European Society of Cardiology 2
- For patients 2-8 weeks post-MI, procedures may be considered with cardiac monitoring, according to the European Society of Cardiology 2
- For patients >8 weeks post-MI with good cardiac recovery, standard gynecological management may be appropriate, as stated by the European Society of Cardiology 2
Anticoagulation and Antiplatelet Therapy
- Administer aspirin 162-325 mg (chewed) upon presentation, as recommended by the American Academy of Family Physicians 6
- Dual antiplatelet therapy (DAPT) should include aspirin 75-100 mg daily indefinitely and a P2Y12 inhibitor for 12 months, according to the American College of Cardiology and European Society of Cardiology 4
- Use routine radial access and drug-eluting stent implantation as the standard of care, and avoid routine thrombus aspiration or deferred stenting, according to the European Society of Cardiology 4
- Administer a loading dose of clopidogrel 300 mg (≤75 years old), then 75 mg daily, as recommended by the American Academy of Family Physicians 6
- Use unfractionated heparin for primary PCI, with enoxaparin or bivalirudin as alternatives, according to the European Society of Cardiology 4
Reperfusion Strategies
- Primary PCI is the preferred reperfusion strategy when available within 90-120 minutes of first medical contact, as recommended by the American Heart Association and European Society of Cardiology 7, 4, 8, 6, 7
- Fibrinolytic therapy should be administered when primary PCI cannot be performed within 120 minutes of first medical contact, and is most effective within the first 2-3 hours of symptom onset, according to the European Society of Cardiology 4, 9, 10, 8, 6, 5
Medical Therapy
- Initiate oral beta-blockers within 24 hours for hemodynamically stable patients, and avoid intravenous beta-blockers in STEMI patients, as recommended by the American Academy of Family Physicians 6
- Beta-blockers should be started within 24 hours for hemodynamically stable patients, with oral treatment indicated for patients with heart failure and/or LVEF <40%, as recommended by the American College of Cardiology and European Society of Cardiology 6, 4, 3
- ACE inhibitors should be started within 24 hours for patients with evidence of heart failure, LV systolic dysfunction, diabetes, or anterior infarct, according to the American College of Cardiology and European Society of Cardiology 4
- High-intensity statin therapy should be started as early as possible, targeting LDL-C <1.8 mmol/L (70 mg/dL) or ≥50% reduction, as recommended by the American College of Cardiology and European Society of Cardiology 4
Contraindications and Precautions
- Patients with certain conditions, such as history of intracranial hemorrhage, significant closed head or facial trauma, uncontrolled hypertension, ischemic stroke, active bleeding, or suspected aortic dissection, have absolute contraindications to fibrinolysis, according to the American Heart Association and European Society of Cardiology 11, 10
- Patients 75 years or older have a higher risk of intracranial hemorrhage with fibrinolysis, and those with a high risk of intracranial hemorrhage should receive primary PCI rather than fibrinolysis, as recommended by the American College of Cardiology 11
- Avoid NSAIDs (except aspirin) due to increased risk of mortality, reinfarction, and heart failure, as recommended by the European Society of Cardiology 10, 12
- Avoid calcium channel blockers as they have not been shown to reduce mortality and may be harmful in certain patients, according to the European Society of Cardiology 3
- Avoid oral nitrates in acute MI due to inability to titrate dose in evolving hemodynamic situations; use IV nitroglycerin instead, as recommended by the European Society of Cardiology 3
- Avoid substituting nitroglycerin for narcotic analgesics in patients requiring pain control, according to the European Society of Cardiology 3
- Avoid fondaparinux for primary PCI due to risk of catheter thrombosis, as recommended by the American College of Cardiology and European Society of Cardiology 4
Rehabilitation and Follow-up
- Cardiac rehabilitation is recommended for all patients following myocardial infarction, according to the American College of Cardiology and European Society of Cardiology 4, 5
- Consider additional diagnostic tests to identify etiology and tailor appropriate therapy for patients with MI but without significant coronary artery stenosis (MINOCA), according to the European Society of Cardiology 4
- Treat severe stenosis in non-IRA lesions before hospital discharge, as recommended by the European Society of Cardiology 4